"CTIX is pleased to announce conclusion of the las
Post# of 72440
Posted On: 03/17/2016 10:11:58 AM
"CTIX is pleased to announce conclusion of the last patient visit in its randomized, double-blind Phase 2 trial of orally-administered Prurisol for the treatment of mild to mid-stage plaque psoriasis. The unblinding of the study and top-line data is expected to be available in May... THERE WERE NO SAFETY ITEMS OF CONCERN."
haven't gotten email with link from the company yet. I think they are avoiding any appearance of impropriety, making sure it hits the wires before we get emails.
haven't gotten email with link from the company yet. I think they are avoiding any appearance of impropriety, making sure it hits the wires before we get emails.
(2)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼